[ad_1]
(MedPage Today) — Patients with juvenile idiopathic arthritis (JIA) who carried the HLA-B27 genetic marker tended to have worse long-term outcomes, including lower rates of drug-free remission, in a prospective Scandinavian study.
Among 434 patients…
[ad_2]
Source link : https://www.medpagetoday.com/rheumatology/arthritis/114788
Author :
Publish date : 2025-03-24 15:15:00
Copyright for syndicated content belongs to the linked Source.
This Biomarker Predicts Very Long-Term JIA Outcomes
Related Posts
